Research Directory

Transgene in vanguard of oncolytic virus therapy

Read more

A new business model for Pharma

Read more

US Special Protocol Assessments for Oncology

Read more

European biotechs start to look undervalued

Read more

An interview with Thomas Lönngren -- Managing change at the EMA

Read more

JAK2 inhibitors: a breakthrough in oncology?

Read more

European Commission lifts funding for innovation

Read more

Boehringer Ingelheim opts for nimble approach

Read more

Affimed brings new antibody to the clinic

Read more

$2 billion in new US funding

Read more